Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Cash from Financing Activities: 2019-2024

Historic Cash from Financing Activities for Molecular Partners Ag (MOLN) over the last 6 years, with Dec 2024 value amounting to $16.4 million.

  • Molecular Partners Ag's Cash from Financing Activities rose 4.10% to $680,229 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year increase of 1380.74%. This contributed to the annual value of $16.4 million for FY2024, which is 1362.60% up from last year.
  • Per Molecular Partners Ag's latest filing, its Cash from Financing Activities stood at $16.4 million for FY2024, which was up 1,362.60% from -$1.3 million recorded in FY2023.
  • Over the past 5 years, Molecular Partners Ag's Cash from Financing Activities peaked at $125.2 million during FY2020, and registered a low of -$1.6 million during FY2022.
  • Its 3-year average for Cash from Financing Activities is $4.5 million, with a median of -$1.3 million in 2023.
  • Per our database at Business Quant, Molecular Partners Ag's Cash from Financing Activities skyrocketed by 54,892.02% in 2020 and then tumbled by 102.97% in 2022.
  • Molecular Partners Ag's Cash from Financing Activities (Yearly) stood at $125.2 million in 2020, then plummeted by 56.19% to $54.9 million in 2021, then slumped by 102.97% to -$1.6 million in 2022, then increased by 20.27% to -$1.3 million in 2023, then spiked by 1,362.60% to $16.4 million in 2024.